Institutional investors purchased a net $3.2 million shares of EW during the quarter ended June 2015 and now own 87.46% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 1.9 Million shares of Edwards Lifesciences Corp
VOYA INVESTMENT MANAGEMENT CO. L... Bought 1.3 Million shares of Edwards Lifesciences Corp